KADIAN 20 mg (Morphine Sulfate Extended-Release 20 mg)
Pill with imprint KADIAN 20 mg is Yellow, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 20 mg. It is supplied by Actavis.
Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for KADIAN 20 mg
Morphine Sulfate Extended-Release
- Imprint
- KADIAN 20 mg
- Strength
- 20 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00228-3502 | Actavis Pharma, Inc. |
| 49884-0833 | Par Pharmaceutical, Inc. |
| 52544-0211 | Watson Pharmaceuticals, Inc. |
| 54868-4571 | Physicians Total Care Inc. (repackager) |
| 35356-0048 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "KADIAN 20 mg"
More about morphine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 329 Reviews
- Drug class: narcotic analgesics
- FDA Alerts (9)
Consumer resources
- Morphine
- Morphine injection
- Morphine Extended-Release Capsules
- Morphine Long-Acting Tablets
- Morphine Immediate-Release Tablets and Capsules
- ... +6 more
Other brands: MS Contin, Roxanol, Kadian, Duramorph, ... +10 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
